Fluidigm has announced that sales of its Biomark system for genetic analysis have surpassed 100 cumulative units in the field.
The Biomark system, based on proprietary microfluidic chips called integrated fluidic circuits (IFCs), provides high-throughput real-time qPCR enabling researchers to streamline their experimental workflow, increase throughput and low costs.
In addition to real-time qPCR, the Biomark system also offers digital PCR, gene expression and genotyping capabilities for researchers.
